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Abstract
Hepatic lipodystrophy in Galloway calves is a fatal liver disease affecting a small proportion of the Galloway breed described in
different parts of Europe and North America during the past decades. The clinical findings include a diversity of neurological signs.
Clinical pathology findings frequently indicate hepatobiliary disease. Postmortem examination reveals an enlarged, pale yellow, and
firm liver. Histologic lesions include hepatic fibrosis, hepatic lipidosis, and bile duct hyperplasia. To date, the etiopathogenesis
remains obscure. Infectious causes, intoxications, and a hereditary origin have been considered. We describe hepatic lipody-
strophy in Galloway calves from an extensively farmed cow-calf operation in southern Germany. Main clinical findings in 6 calves
were consistent with hepatic encephalopathy. Clinical pathology findings in 5 of 6 tested animals revealed increased concentration
of total bilirubin (maximum value [MV], 54 mmol/l; reference range [RR], <8.5 mmol/l), direct bilirubin (MV, 20 mmol/l; RR, <3.4
mmol/l), increased activity of gamma glutamyl transferase (MV, 162 U/l; RR, <36 U/l) and glutamate dehydrogenase (MV, 420 U/l;
RR, <16 U/l). In addition, activity of glutathione peroxidase was decreased in all tested (n ¼ 5) animals (MV, 61 U/g hemoglobin
[Hb]; RR, >250 U/g Hb). Postmortem examination in 6 calves revealed a firm, diffusely enlarged yellow liver with a finely nodular
surface. Histologic lesions included hepatic fibrosis, hepatic lipidosis, and bile duct hyperplasia. Our findings add to the existing
data on hepatic lipodystrophy in the Galloway breed and outline a protocol to aid in the diagnosis of this disorder.
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Hepatic lipodystrophy in Galloway calves was first recognized
in 1965 in Scotland with the first published report in 1982 by
Stewart and others.45 It has been reported in England,7
Canada,15 the United States,31 and possibly Iceland.26 Based
on the small number of reports that were identified in the
literature, animal-level prevalence (within the Galloway popu-
lation) and herd-level prevalence (of all Galloway operations)
of this disease appear to be relatively low. However, in affected
herds, within-herd prevalence has been reported to be remark-
ably high, affecting up to 10% of the offspring in some cases.7
Hepatic lipodystrophy has been reported to affect exclu-
sively calves of the Galloway breed, with only 2 recently
documented crossbred calves.46 The objective of the present
report was to describe the clinical and pathologic findings in
cases of hepatic lipodystrophy in a Galloway herd in southern
Germany.
Materials and Methods
Background
During June 2011 and February 2013, a total of 7 purebred
Galloway calves were referred to the Clinic for Ruminants,
University of Munich. The calves originated from an exten-
sively farmed cow-calf operation herd with a total of 10 cows,
5 replacement heifers, and 1 breeding bull. The animals were
on the same pasture year-round (approximate size 2 hectares).
A shed was provided for weather protection and was bedded
with straw purchased from a neighboring farm. All animals had
free access to hay and grass silage from 2 different pastures of
the farm as well as to water from the municipal water supply.
No mineral supplementation was offered to the animals. Prior
to the referral of the first calf, 3 calves at the age of 2 to
3 months died in April 2011, showing similar clinical signs
according to the owner’s report. Postmortem examination was
performed in 1 of the 3 calves at the Department of Veterinary
Pathology of the Bavarian Health and Food Safety Authority,
Oberschleissheim, and revealed a firm, diffusely enlarged yel-
low liver with a finely nodular surface. Histologic lesions
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included hepatic fibrosis, hepatic lipidosis, and bile duct hyper-
plasia. No lesions indicating white muscle disease were
observed. Investigation of the trace element status via photo-
metric analyses (Fe, iron; Cu, copper; Zn, zinc) and inductively
coupled plasma optical emission spectrometry (ICP-OES; Se,
selenium) of serum samples taken from 5 animals in June 2011
by the Bavarian Animal Health Service revealed a severe sele-
nium deficiency. Examination of all forages did not lead to any
evidence of the underlying cause of the reported disease. The
owner observed serious behavioral changes in all affected
calves several days prior to admission to the clinic. The animals
at 1 to 10 weeks of age were depressed and were lying isolated
from the herd, became progressively debilitated, showed only
weak attempts to suckle, and became increasingly reluctant to
follow their dams. They could easily be approached without
eliciting a flight reflex. When forced to rise and trot, the calves
showed a typical posture with the head carried very low and
nodding listlessly. According to the owner’s opinion, the 7
calves that were referred to the clinic over a period of 20 months
presented in various stages of the same disease. One calf died
during transport and was sent to the Department of Veterinary
Pathology of the Bavarian Health and Food Safety Authority,
Oberschleissheim, for postmortem examination. A total of 6
calves were available for clinical examination and bloodwork.
Immediately after arrival at the clinic, blood was taken from
each animal by venipuncture of the jugular vein and
placed directly into S-Monovette (Sarstedt, Nu¨mbrecht-
Rommelsfeld, Germany), anticoagulant (K3 EDTA, 1.6 mg/
ml; Sarstedt), and blood gas Monovette (50 IU/ml of
calcium-balanced lithium heparin; Sarstedt) tubes. Blood sam-
ples were processed immediately, and serum was harvested by
centrifugation at 3000 rpm for 10 minutes at 25C. All serolo-
gical parameters, as well as the activity of glutathione perox-
idase in whole blood, were determined using an automatic
analyzing system (Automatic Analyzer Hitachi 911; Roche
Diagnostics, Indianapolis, IN). Hematological analyses were
performed with an automatic hematology analyzer (Sysmex
F820; Sysmex, Norderstedt, Germany).
Necropsy of 6 calves was carried out at the Department of
Veterinary Pathology of the Bavarian Health and Food Safety
Authority, Oberschleissheim. Samples of liver, brain, myocar-
dium, and kidney of all calves; major muscles of the thigh and
shoulder of 4 calves (Nos. 1, 4, 5, and 6); spleen of 3 calves
(Nos. 5, 6, and 7); lung of 3 calves (Nos. 1, 4, and 7); and
hepatic lymph node of 2 calves (Nos. 4 and 6) were collected
for light microscopy. Formalin-fixed, paraffin-embedded tis-
sues were routinely processed for histological examination and
stained with hematoxylin and eosin (HE). Liver specimens
were stained with Goldner’s trichrome staining of connective
tissue and Oil Red O for lipids.
Results
Clinical Signs and Clinical Pathology
At the time of hospitalization, 5 of the 6 calves predominantly
demonstrated impairment of the sensorimotor system ranging
from slight depression to coma with intermittent seizures and
tenesmus. Table 1 shows baseline characteristics and results of
clinical examination of the 6 calves at the time of hospitaliza-
tion. Hematological and clinical chemistry findings are demon-
strated in Table 2. Abnormal findings included an increase of
liver-specific parameters in 5 calves and hypoglycemia in 4
calves. L-lactatemia could be detected in 2 calves and hypal-
buminemia in 1 calf. In 5 of 5 tested calves, the activity of
glutathione peroxidase was below the reference range (RR).
Treatment and Clinical Course
Based on the severity of clinical signs, calf No. 2 was
euthanized immediately after completion of the clinical exam-
ination. Treatment for the remaining 5 calves consisted of
Table 1. Baseline Characteristics and Clinical Findings at the Time of Hospitalization of 7 Galloway Calves Referred to the Clinic Over a Period
of 20 Months.
Parameter Calf 1 Calf 2 Calf 3 Calf 4 Calf 5 Calf 6
Calf 7 (Dead
at Arrival)
Age, wk 6.1 8.1 8.1 5.1 9 9 1
Sex Female Male Male Male Female Female Female
Body weight, kg 53 80 85 60 70 75 45
Body condition Poor Good Good Good Poor Good Poor
Posture Drooping
of head
Lateral
recumbency
Unremarkable Unremarkable Lateral
recumbency
Arched back, drooping
of head and tongue
NA
Behavior Apathic Comatose, tonic-
clonic seizures,
tenesmus
Unremarkable Apathic Somnolent Intermittently apathic,
tenesmus
NA
Heart rate, beats per
minute
132 112 92 148 100 140 NA
Respiratory rate,
breaths per minute
96 28 32 140 68 60 NA
Rectal temperature, C 39.8 40.3 39.2 40.3 39.8 39.3 NA
NA, not assessed.
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vitamin E (tocopherol acetate, 10 mg/kg bodyweight [BW],
subcutaneously [s.c.]) and sodium selenite (0.3 mg/kg BW,
s.c.) in a combined preparation (Vitamin E-Selen-Lo¨sung;
CP-Pharma, Burgdorf, Germany), a nonsteroidal anti-
inflammatory drug (meloxicam, 0.5 mg/kg BW, s.c.; Metacam,
Boehringer Ingelheim, Ingelheim am Rhein, Germany), and an
antimicrobial drug (gamithromycin, 6 mg/kg BW, s.c.; Zactran,
Biokema SA, Merial, Hallbergmoos, Germany). Three calves
(Nos. 4, 5, and 6) with hypoglycemia received a continuous
intravenous infusion containing 5 liters of 0.9% sodium chlor-
ide solution (Isotone Natriumchlorid-Lo¨sung ad usum veteri-
narium; B. Braun, Melsungen, Germany) and 1 liter of 40%
dextrose solution (Glucose 40% ad usum veterinarium; B.
Braun). One of these 3 calves (calf No. 5) died unexpectedly
within several hours after arrival at the clinic. Calf No. 6 was
euthanized 24 hours after arrival at the clinic because of rapid
progression of the disease. Deterioration of the general con-
dition and liver-specific parameters (aspartate aminotransfer-
ase [AST], 216 U/l [RR, <80 U/l]; gamma glutamyl
transferase [GGT], 173 U/l [RR, <36 U/l]; glutamate dehy-
drogenase [GLDH], 63 U/l [RR, <16 U/l]) within 4 days was
documented in calf No. 1. Five days after hospitalization, the
calf was found in lateral recumbency showing tonic-clonic
seizures and opisthotonus and was euthanized. A temporary
improvement concerning the general condition and liver-
specific parameters (AST, 58 U/l; GGT, 82 U/l; GLDH,
111 U/l) could be documented in calf No. 4. However, the
general condition deteriorated peracutely 7 days after hospi-
talization. The calf showed central nervous signs (bawling,
tonic-clonic seizures) and was euthanized. Calf No. 3 never
showed any signs of disturbance of the general condition.
Parameters of clinical chemistry on days of admission and
discharge were unremarkable.
Pathological Findings
Postmortem examination revealed similar findings in all
calves with some variation in the youngest calf (calf No.
7). The most obvious lesion was a firm, diffusely enlarged
yellow liver with a finely nodular surface (Figs. 1–3). The
gallbladder was severely distended with unremarkable bile
(Fig. 3). Liver samples did not float in formalin. Histologi-
cally, livers were characterized by marked loss of hepato-
cytes, prominent hepatic lipidosis, severe diffuse hepatic
fibrosis, and bile duct hyperplasia. Hepatocytes showed
macrovesicular vacuoles staining with Oil Red O for lipids
and displacing the nucleus to the periphery of the cell
(Figs. 6, 7). Single necrotic hepatocytes were present as
well as a small number of megalocytes. In the fibrotic areas,
small foci of mononuclear inflammatory cell infiltrates were
present. There was no accumulation of lipofuscin or any
other pigments in hepatocytes or in Kupffer cells. Hepatic
lymph nodes were moderately enlarged and edematous as
confirmed histologically.
The liver of the youngest calf (calf No. 7) was enlarged and
orange-brown in color, of nodular texture, and softer than nor-
mal (Figs. 4, 5). Hepatic lipidosis with macrovesicular vacuo-
lization was the most obvious histological finding in this calf.
There was only mild hepatic fibrosis that exhibited a portal
distribution. Necrosis of small groups of hepatocytes and hepa-
tocellular cholestasis were present. The gallbladder of this ani-
mal was filled with watery bile.
Table 2. Results of Hematological Analysis and Clinical Chemistry of 6 Galloway calves referred to the Clinic Over a Period of 20 Months.a
Parameter Reference Rangeb Calf 1 Calf 2 Calf 3 Calf 4 Calf 5 Calf 6
Erythrocytes, Tc/l 5–8 10.9 6.0 8.1 11.6 10.9 12.6
Hematocrit, % 30–36 53.1 27.0 34.1 45.1 44.2 49.9
Thrombocytes, Gd/l 200–800 333 39 181 498 311 636
Leukocytes, Gd/l 4–10 14.2 22.5 7.2 18.1 15.8 20.9
Albumin, g/l 30–40 37 18 43 34 31 31
Total bilirubin, mmol/l <8.5 11 26 2 43 53 54
Direct bilirubin, mmol/l <3.4 NA 18 NA 13 19 20
AST, U/l <80 131 449 46 67 392 649
GGT, U/l <36 162 51 18 107 44 45
GLDH, U/l <16 28 75 30 127 133 420
CK, U/l <245 727 19000 160 145 1903 10430
GPX, U/g Hb >250 33 NA 61 45 32 33
L-lactate, mmol/l <2.2 2.4 12 1.5 2.5 2.5 2.9
Glucose, mmol/l 3.9–6.6 4.5 <0.1 5.5 2.8 2.1 2.0
Iron, mmol/l 12–44 50.1 NA 35.0 16.3 9.3 13.6
Copper, mmol/l 8–39 2.7 NA 6.1 8.3 4.9 9.7
Zinc, mmol/l 10–20 11.1 NA 10.7 16.1 8.2 15.9
AST, aspartate aminotransferase; CK, creatine kinase; GGT, gamma glutamyl transferase; GLDH, glutamate dehydrogenase; GPX, glutathione peroxidase;
Hb, hemoglobin; NA, not assessed.
aBlood samples were taken from the jugular vein immediately after arrival at the hospital.
bReference ranges assessed at Clinic for Ruminants, University of Munich.
cT ¼ Tera (1012).
dG ¼ Giga (109).
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Furthermore, necropsy revealed obvious icterus of 2 calves
(Nos. 6 and 7). Five of the 6 calves were emaciated, and 2 were
cachectic (Nos. 1 and 5) as indicated by serous atrophy of
epicardial fat.
Histologically, the brain of 2 calves (Nos. 4 and 6) showed
acute spongiform changes, especially in the cerebral cortex. Due
to mild autolysis, it was not possible to critically examine the
brains of the other 4 calves for lesions of hepatic encephalopathy.
Figures 1–5. Hepatic lipodystrophy, liver and gallbladder; bovine. Figures 1 and 2. Calf No. 5, diffusely enlarged yellow liver with finely
nodular surface and diffuse yellow cut face. Figure 3. Calf No. 6, finely granular surface of the liver and severely distended gallbladder.
Figures 4 and 5. Calf No. 7, orange-brown discoloration and nodular cut surface.
Figures 6 and 7. Hepatic lipodystrophy, liver; bovine. Figure 6. Loss of hepatocytes, hepatic lipidosis, and bile duct proliferation are
prominent. Hematoxylin and eosin. Figure 7. There is extensive fibrosis. Goldner’s trichrome.
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Light microscopic examination of major muscles of the
thigh and shoulder and myocardium revealed no evidence of
nutritional myodegeneration. Histologic examination of kid-
neys und lungs yielded moderate hyperemia. Further secondary
findings were bronchopneumonia of the cranioventral regions
of the lung (3 calves), enteritis (3 calves), and abomasal ulcera-
tion (2 calves). Spleen specimens showed no histological
alterations. Bacteriological testing revealed no relevant infec-
tious agents in thoracic and abdominal organs.
Liver samples of 2 calves (Nos. 2 and 7) were submitted to
the Pharmaceutical Institute, University of Bonn, Germany,
and analyzed via gas chromatography and gas chromatogra-
phy–mass spectrometry.40,55 A metabolite of pyrrolizidine
alkaloids (PAs) was found in 1 calf (No. 2). Investigation of
a liver sample of the same calf for concentration of selected
mycotoxins via enzyme-linked immunoassay (aflatoxin,14
deoxynivalenol [DON],13 ochratoxin A29) at the BioCheck
laboratory services GmbH (Leipzig, Germany) revealed a con-
centration of DON of 99.6 mg/kg (RR, <20 mg/kg, assessed at
BioCheck laboratory services GmbH), whereas concentration
of aflatoxin and ochratoxin A was below the detection limit of
0.05 mg/kg. Moreover, concentration of hepatic copper and
cobalt was analyzed from 1 calf (No. 7) at the Bavarian Health
and Food Safety Authority (Oberschleissheim, Germany) using
ICP-OES and inductively coupled plasma mass spectrometry
(ICP-MS) as described in Section 64 of the German Food and
Feed Code. Copper was determined to be below the reference
range (23.8 mg/kg wet weight; RR, 30–150 mg/kg39), whereas
cobalt concentration was marginal but not deficient (0.015 mg/
kg wet weight; RRs: deficient, <0.005; marginal, 0.005–0.017;
adequate, 0.020–0.085 mg/kg wet weight38).
Further Investigations
Investigation of serum samples from the respective dams
yielded no elevation of liver-specific parameters. However, a
severe reduction of activity of glutathione peroxidase could
also be detected in adults (range, 9–15 U/g hemoglobin [Hb];
RR, >250 U/g Hb). In addition, selenium deficiency could be
confirmed by measuring selenium by ICP-MS in the plasma of
5 cows (range, 5.3–11.4 mg/l; RR, >50 mg/l, assessed at the
University of Veterinary Medicine Hannover, Foundation,
Germany). A botanical investigation of a hay sample at the
Pharmaceutical Institute, University of Bonn, Germany, did not
give any evidence of PA-containing plants. Moreover, an
inspection of the pasture was carried out by a botanist of the
Bavarian Institute for Agriculture, in which a small amount of
comfrey (Symphytum officinale) was found.
Discussion
To our knowledge, this is the first report on hepatic lipodystro-
phy in Galloway calves in Germany with a particularly high
within-herd prevalence affecting 40% of the offspring in the
years 2011 to 2013. While apparent herd-level and animal-
level prevalence of the general Galloway population appear
to be low, the true prevalence is not established. This might
be further complicated by the fact that herd investigations,
including necropsies, are only carried out in cases where a
sudden increase of mortality within a herd is considered alarm-
ing. It is therefore possible that single cases of hepatic lipody-
strophy might go unnoticed, and cases are attributed to
concurrent calfhood diseases, such as diarrhea and pneumonia,
which have been recorded in affected calves.7,26
In most cases, the disease leads to clinical signs at 2 to
4 months of age.26 The oldest calf was 5 months old.26 In
addition, abortions and stillborn calves have been
reported.7,26,46 While in the present case, most affected calves
(5/6) have been within the characteristic age,26 1 calf was only
1 week old and represents the youngest clinical case of docu-
mented hepatic lipodystrophy.
The predominant clinical signs as reported by the owner and
documented after hospitalization show an involvement of the
central nervous system consistent with hepatic encephalopathy
as reported by others.7,15,26,46
Laboratory parameters only have been documented in a total
of 4 calves from 2 different studies,7,26 with no general pattern
of alterations. Although alterations of laboratory parameters in
samples from calves in this study reflect different stages of the
disease, a characteristic pattern of changes of liver-specific
parameters was documented. Increased activity of AST in 4
cases might be at least partially due to muscle cell damage and
can be attributed to the massive selenium deficiency leading to
myodystrophy. This evidence is also underlined by the large
increase in activity of creatine kinase (CK) in 2 calves (Nos. 2
and 6).52 In this regard, the remarkable selenium deficiency as
determined by activity of glutathione peroxidase, ICP-OES,
and ICP-MS is noteworthy. Remarkable differences in the pro-
portion of selenium-dependent and non-selenium-dependent
glutathione peroxidase activity exist among different species.25
It is therefore possible that Galloway cattle have a high pro-
portion of selenium-dependent glutathione peroxidase in liver
tissue compared to other species and breeds, resulting in a high
susceptibility to oxidative stress and consequent hepatopathy
when selenium intake is deficient. Considering the massive
selenium deficiency, one should expect calves to be affected
by coagulative necrosis of the skeletal muscles. The lack of
such histological findings in skeletal muscles and myocardium
might be due to the sufficient vitamin E intake through grazing,
which might prevent some manifestations of selenium defi-
ciency to a certain extent. However, because vitamin E status
was not determined in any of the calves, this possible explana-
tion remains to be tested. Hypoglycemia, as described in 4
cases, can be caused by massive liver cell damage,43 which
leads to L-lactatemia as previously described.35,43
The case definition of hepatic lipodystrophy in Galloway
calves is the presence of the aforementioned characteristic clin-
ical signs in association with hepatic lipidosis,7,15,26,46 which
was documented at different degrees in all 6 animals necrop-
sied. Hepatic lipidosis refers to a visible accumulation of tri-
glycerides as round vacuoles in the cytoplasm of hepatocytes
and can result from a variety of different disorders, including
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intoxications, nutritional deficiencies, metabolic disease, and
inherited defects in lipid metabolism.44 Several stages of hepa-
tic lipid metabolism can be impaired by numerous toxins, caus-
ing hepatic lipid accumulation.44 Among the toxins most
relevant for cattle in Germany are aflatoxins,5 DON,48 and
PAs.20 DON and PA concentrations above the RR were
detected in the liver of 1 affected calf.
Considering the age of affected calves (1 to 9 weeks in the
present report plus aborted and stillborn calves in other
reports7,26,45), the possibility of transplacental transmission and
transmission into the milk following ingestion of toxins by the
dam has to be taken into account. Transplacental transmission
of aflatoxins in calves causing liver cirrhosis has been
reported,1 as has been the case for transmission into the milk
from animals fed with feeds containing aflatoxin B1.11,34
Transfer of DON to milk following ingestion of the preformed
toxin by the dam has been reported to be very low, with an
estimated 0.0001% of the ingested dose excreted in milk.36
Transplacental transmission of DON has been observed in
rats4, pigs49, and humans30; however, no detrimental effects
on the liver of the respective fetuses could be detected.4,49
No reliable data about fetotoxic effects of PAs have been
reported. In contrast to reports of studies showing a transpla-
cental transfer of PAs,9,10,42 1 experimental study failed to
detect abnormalities in fetuses after feeding a lethal dose to
the respective dams.20 While excretion of PAs into the milk
could be detected,17,28 no consensus of its effects after inges-
tion by the respective newborn and suckling animals exists.
Dickinson and colleagues6 could not detect any histological
alterations of the liver or increased concentration of liver-
specific parameters in newborn calves after feeding a nonlethal
dose of PAs to the respective dams. In another experimental
study, a lethal dose of Senecio jacobaeawas fed to dams.19 The
respective calves showed increased concentration of liver-
specific parameters. However, no characteristic histological
alterations could be detected.19 While in the present case, com-
frey was the only PA-containing plant that was found in the
pasture, it seems to be unlikely—according to the present
knowledge—that single ingestion of comfrey can cause such
severe clinical and pathological alterations, especially given
the high prevalence of the described condition.
Notwithstanding, we cannot exclude with certainty that a
possible intoxication of the calves has been caused by ingestion
of more than 1 PA-containing plant other than comfrey. Due to
the year-round grazing, animals in this herd have access to the
sprouting young plants containing PAs in the spring, which
have less of a bitter taste and, therefore, can be ingested, espe-
cially by inexperienced young animals.33 Although the inves-
tigation of all forages did not yield any evidence for the
presence of the toxins, we cannot exclude an interaction of
more than one of the aforementioned toxins. Another aspect
might be the fact that the young animals do not have a fully
developed rumen and, therefore, are more sensitive to PAs than
adult animals who have the capacity to inactivate certain toxins
during ruminal passage.54 It is therefore quite possible that the
massive selenium deficiency would have had a negative impact
on the individual resilience of affected calves not only to PA
intoxication but also to other toxins such as aflatoxins
and DON.
As a component of glutathione peroxidase, selenium has a
direct influence on the glutathione homeostasis. The impor-
tance of intracellular glutathione on toxin elimination of PAs
has been shown in numerous studies.3,18,56 In addition, quali-
tative and quantitative species differences in the liver capacity
of glucuronidation are said to be responsible for insensitivity to
senecio-alkaloids of some animal species.16
A further type of hepatic lipidosis associated with encepha-
lopathy, named ‘‘white liver disease,’’ has been described con-
currently with cobalt deficiency in sheep22,24 and goats,21
causing a decreased activity of the vitamin B12–dependent
enzymes methyl-malonyl-CoA mutase23 and methionine
synthase22 and a consequent accumulation of branched-chain
fatty acids (BCFAs) in hepatocytes.24 Histologically, livers
were characterized by fatty degeneration of hepatocytes, cho-
langiolar hyperplasia, and hepatic megalocytosis similar to the
findings observed in this study but also by a prominent lipo-
fuscin accumulation in degenerated hepatocytes and in Kupffer
cells,24,50,51 which was absent in the cases described here.
Hemosiderosis of the spleen is also common in ovine white
liver disease.51 In contrast, lipofuscin and hemosiderin accu-
mulation is lacking in the organs of the presented calves. How-
ever, this characteristic manifestation of cobalt deficiency
might be restricted to sheep and goats2 due to a species-
specific high rate of methyl-malonyl-CoA activity leading to
higher rates of BCFA synthesis compared to cattle.8 Finally,
because hepatic cobalt concentration was determined to be
within normal limits in calf No. 7, we consider a disorder
similar to ‘‘white liver disease’’ in sheep and goats unlikely
to be the cause of the findings in the calves described herein.
Another nutritional deficiency causing myopathy and hepa-
tic lipidosis in weaned lambs is vitamin E deficiency.27 How-
ever, vitamin E deficiency seems to be unlikely in animals on
pasture. There was no evidence of myopathy from histological
examination in the calves described herein.
A hereditary abnormality within the Galloway breed has to
be considered as a possible cause or as a contributing factor in a
multifactorial disease complex, as suggested by the breed pre-
disposition of this disease.7,26,45,46 Familial hyperlipoproteine-
mia in cats,47 idiopathic hyperlipoproteinemia in dogs,41 and
congenital generalized lipodystrophies in humans32 have been
identified to be inherited defects in lipid metabolism. In the
present case, all affected calves were the progeny of 1 bull that
had been introduced into the herd in 2010 and was slaughtered
in 2013. The most recent consultation with the owner revealed
no new cases in 2014 and 2015. However, no genetic analysis
has been performed to date.
The term hepatic lipodystrophy in association with Gallo-
way cattle derives from the first report on ‘‘a fatal condition of
pedigree Galloway calves’’ by Stewart and others.45 The
authors documented a characteristic clinical pattern and unique
pathological findings that are similar to the ones described
herein. To this date, several authors7,15,26 have referred to this
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concept. In human medicine, the term lipodystrophy describes
a group of syndromes in which the primary defect is a lack of
intraabdominal or subcutaneous adipose tissue and an accumu-
lation of fat depots in muscle tissue and central organs.12 The
cardinal features include insulin resistance, dyslipidemia
reflected by hypertriglyceridemia, and liver steatosis.53
According to the cause and the anatomical distribution of adi-
pose tissue, lipodystrophies are classified as genetic or acquired
and generalized or partial, respectively.37 Although the
increased concentration of serum lipids in 2 calves and trigly-
cerides in 1 calf as reported by Macleod and Allison26 offers
some evidence that this disease of Galloway calves is a bovine
form of lipodystrophy, the proof is still lacking. Further inves-
tigations, including testing of the concentration of insulin in
blood possibly enhanced by a glucose tolerance test, as well as
blood concentration of lipids, namely triglycerides, have to be
carried out indicating the described phenomenon being a lipo-
dystrophy as defined in human medicine.37
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